MAPT and cardiac arrest: In addition, given the first time point measured in this study was 24 hours after cardiac arrest, when p-tau has already reached its peak, further studies should examine p-tau as an ultra-early prognostic biomarker of neurological outcome in cardiac arrest and other acute neurological disorders.